Trial · NCT01950520
Results by group22
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 22
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Resting Energy Expenditure at Low Temperature | Cohort 1 | Placebo Cohort 1 | 1.277 | Standard Deviation 0.151 | kcal/min |
| Resting Energy Expenditure at Low Temperature | Cohort 1 | Propranolol | 1.134 | Standard Deviation 0.109 | kcal/min |
| Resting Energy Expenditure at Low Temperature | Cohort 1 | Dantrolene | 1.300 | Standard Deviation 0.118 | kcal/min |
| Resting Energy Expenditure at Low Temperature | Cohort 1 | Magnesium sulfate | 1.271 | Standard Deviation 0.126 | kcal/min |
| Resting Energy Expenditure at Low Temperature | Cohort 1 | Pindolol | 1.165 | Standard Deviation 0.112 | kcal/min |
| Resting Energy Expenditure at Low Temperature | Cohort 2 | Caffeine | 1.292 | Standard Deviation 0.123 | kcal/min |
| Resting Energy Expenditure at Low Temperature | Cohort 2 | Phentermine | 1.217 | Standard Deviation 0.116 | kcal/min |
| Resting Energy Expenditure at Low Temperature | Cohort 2 | Topiramate | 1.191 | Standard Deviation 0.122 | kcal/min |
| Resting Energy Expenditure at Low Temperature | Cohort 2 | Qsymia | 1.228 | Standard Deviation 0.122 | kcal/min |
| Resting Energy Expenditure at Low Temperature | Cohort 2 | Naltrexone | 1.185 | Standard Deviation 0.140 | kcal/min |
| Resting Energy Expenditure at Low Temperature | Cohort 2 | Placebo | 1.215 | Standard Deviation 0.109 | kcal/min |
| Resting Energy Expenditure at Low Temperature | Cohort 3 | Placebo for Mirabegron | 1.25 | Standard Deviation 0.39 | kcal/min |
| Resting Energy Expenditure at Low Temperature | Cohort 3 | Mirabegron 50mg | 1.31 | Standard Deviation 0.19 | kcal/min |
| Resting Energy Expenditure at Low Temperature | Cohort 3 | Mirabegron 200mg | 1.37 | Standard Deviation 0.19 | kcal/min |
| Basal Metabolic Rate | Cohort 1 | Placebo Cohort 1 | 1.153 | Standard Deviation 0.098 | kcal/min |
| Basal Metabolic Rate | Cohort 1 | Propranolol | 1.053 | Standard Deviation 0.099 | kcal/min |
| Basal Metabolic Rate | Cohort 1 | Dantrolene | 1.143 | Standard Deviation 0.105 | kcal/min |
| Basal Metabolic Rate | Cohort 1 | Magnesium sulfate | 1.108 | Standard Deviation 0.124 | kcal/min |
| Basal Metabolic Rate | Cohort 1 | Pindolol | 1.116 | Standard Deviation 0.109 | kcal/min |
| Brown Adipose Tissue Activity (Cohort 3 Only) | Cohort 3 | Placebo for Mirabegron | 0.1 | Standard Deviation 0.2 | mL*SUVmean*g/mL |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01950520/results